Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
BGNE BeiGene
- 206.010
- +0.260+0.13%
Close Dec 3 16:00 ET
- 206.010
- 0.0000.00%
Post 16:01 ET
21.89BMarket Cap-25001P/E (TTM)
208.230High202.635Low395.22KVolume206.220Open205.750Pre Close81.46MTurnover0.65%Turnover RatioLossP/E (Static)106.25MShares248.16052wk High6.50P/B12.57BFloat Cap126.96852wk Low--Dividend TTM61.01MShs Float426.560Historical High--Div YieldTTM2.72%Amplitude22.510Historical Low206.108Avg Price1Lot Size
About BeiGene Company
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Company Profile
SymbolBGNE
Company NameBeiGene
Listing DateFeb 3, 2016
Issue Price24.00
Founded2010
CEOMr. John V. Oyler
MarketNASDAQ
Employees10600
Securities TypeDR
ADS Ratio1.0 : 13.0
Fiscal Year Ends12-31
Address94 Solaris Avenue,Camana Bay,Grand Cayman
CityGeorge Town
ProvinceGeorge Town
CountryCayman Islands (the)
Zip CodeKY1-1108
Phone1-345-949-4123
Websitehttp://www.beigene.com
Company Executives
- Name
- Position
- Salary
- John V. Oyler
- Chief Executive Officer and Chairman of the Board
- 18.93M
- Dr. Xiaobin Wu, PhD
- President, Chief Operating Officer and General Manager, China
- 11.00M
- Titus B. Ball
- Principal Accounting Officer
- --
- Chan Henry Lee
- Senior Vice President, General Counsel and Assistant Secretary
- 3.04M
- Shalini Sharp
- Director
- --
- Dr. Olivier Raymond Brandicourt, M.D.
- Director
- --
- Qingqing Yi
- Independent Director
- 487.05K
- Dr. Margaret Dugan
- Independent Director
- 510.55K
- Dr. Alessandro Riva, M.D.
- Independent Director
- 491.67K
- Donald W. Glazer
- Independent Director
- 480.80K
- Anthony C. Hooper
- Independent Director
- 513.15K
- Michael J. Goller
- Independent Director
- 3.04M
- Dr. Corazon Dating Sanders, PhD
- Independent Director
- 501.55K
- Ranjeev Krishana
- Lead Independent Director
- 487.05K
- Dr. Xiaodong Wang, PhD
- Independent Director
- 4.42M
- Dr. Lai Wang, PhD
- Global Head of Research and Development
- 7.32M
- Aaron Rosenberg
- Chief Financial Officer
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
